The recombinant protein is synthesized in E. coli, followed by chromatographic purification.
Prolactin Ovine, His binds to prolactin receptors (PRLR) in target tissues, activating signaling pathways such as JAK-STAT and MAPK . Key functional insights include:
Induces proliferation of Nb2 rat lymphoma cells, confirming bioactivity .
Regulates ovarian granulosa cell (GC) apoptosis and steroidogenesis .
Low concentrations (0.05–5.00 µg/mL): Modulate estrogen (E₂) and progesterone (P₄) secretion in GCs .
High concentrations (>20 ng/mL): Promote GC apoptosis via upregulation of MAPK12 and suppression of PRLR isoforms (L-PRLR, S-PRLR) .
Mammotropin, Luteotropic hormone, Luteotropin, PRL.
Escherichia Coli.
Ovine prolactin (oPRL) refers to prolactin derived from sheep sources. It has emerged as a significant research tool due to its involvement in multiple physiological aspects of reproduction. Current evidence suggests prolactin plays roles in oocyte competence, corpus luteum formation and survival, endometrial receptivity, blastocyst implantation, and sperm survival . The histidine-tagged version (Prolactin Ovine, His) provides enhanced purification capabilities while maintaining biological activity, making it valuable for investigating prolactin's pleiotropic functions in reproduction, growth, metabolism, and immunology.
Ovine prolactin exists in several isoforms, with the monomeric form (small, potent isoform) being the predominant type found in follicular fluid during IVF procedures . The histidine tag addition enables affinity purification without significantly altering biological activity in most experimental systems. The structural characteristics of ovine prolactin allow it to bind to prolactin receptors (PRLR) expressed in various reproductive tissues, including granulosa cells and corpus luteum . This receptor-ligand interaction triggers downstream signaling pathways that regulate cellular functions such as proliferation, apoptosis, and hormone production.
Immunohistochemistry represents the primary methodology for identifying prolactin receptor expression in ovine reproductive tissues. As demonstrated in recent research, this technique has successfully identified PRLR expression in both follicular granulosa cells and corpus luteum of small-tail Han sheep . For quantitative analysis of receptor expression, researchers commonly employ real-time quantitative polymerase chain reaction (RT-qPCR) to measure mRNA levels and Western blotting to quantify protein expression. These complementary approaches provide comprehensive insight into receptor distribution and abundance across different reproductive tissues and cellular compartments.
Ovine prolactin exhibits regulatory effects on microtubule dynamics in the anterior pituitary, demonstrating a feedback mechanism controlling its own secretion. Experimental evidence shows that suckling induces a 25% reduction in soluble tubulin and a 40% increase in polymerized tubulin in the anterior pituitary lobe . Importantly, administration of ovine prolactin (3 mg) 4 hours before suckling significantly inhibits both the suckling-induced increase in polymerized tubulin and subsequent plasma prolactin elevation . Additionally, oPRL administration causes approximately 25% reduction in total tubulin levels (soluble and polymerized) in suckled rats, suggesting prolactin regulates the tubulin pool available for microtubule formation. This mechanism appears integral to the autoregulation of prolactin secretion and represents a potential target for modulating prolactin-related reproductive disorders.
Research on the relationship between follicular fluid prolactin concentrations and oocyte competence has yielded somewhat contradictory results. Several studies have found positive correlations between higher follicular fluid prolactin levels and increased oocyte competence. Specifically, Lindner et al. demonstrated that oocyte maturation and fertilization capacity were predicted by higher prolactin content in follicular fluid . Similarly, Subramanian's research confirmed that mature preovulatory follicles contained significantly greater concentrations of prolactin compared to immature follicles . Laufer et al. further linked higher follicular fluid prolactin levels with increased successful pregnancies .
Ovine prolactin exerts concentration-dependent effects on granulosa cell function and steroidogenesis. Current research demonstrates that prolactin can modulate granulosa cell proliferation and apoptosis rates, with apoptosis significantly increasing at 0.05 μg/mL concentration compared to control groups (p<0.05) . Regarding steroidogenesis, prolactin demonstrates dual effects: inhibiting estradiol production while stimulating progesterone production in granulosa cells .
The molecular mechanisms involve prolactin reducing aromatase activity (thereby decreasing estradiol synthesis) while amplifying FSH-induced steroidogenic acute regulatory protein, P450 side-chain cleavage enzyme, and 3β-hydroxysteroid dehydrogenase type 2 levels (thereby increasing progesterone synthesis) . These effects appear mediated through distinct signaling pathways activated upon prolactin receptor binding. The biphasic nature of prolactin's effects underscores the importance of precise concentration control in experimental designs.
Prolactin exhibits critically important biphasic dose-dependent effects on oocyte maturation that significantly impact experimental design considerations. At moderate concentrations (approximately 50 ng/mL), prolactin decelerates abnormal chromosome changes in cumulus-enclosed aging oocytes, suggesting a protective effect . Conversely, at concentrations 10-20 times higher than the normal physiological range, prolactin enhances destructive changes in oocytes . This biphasic response appears mediated through cumulus cells, as denuded oocytes fail to show these effects, implicating prolactin receptors in cumulus cells as critical mediators of prolactin's action on oocyte quality .
These findings have substantial implications for in vitro fertilization protocols and highlight why precise concentration control is essential when using prolactin in reproductive research. The data suggests an optimal therapeutic window exists for prolactin supplementation in reproductive technologies.
Purification of biologically active His-tagged ovine prolactin requires a strategic multi-step approach. The addition of histidine tags facilitates metal affinity chromatography, typically using nickel or cobalt resins with imidazole elution gradients. Critical considerations include buffer composition (particularly pH and ionic strength), which significantly affects binding efficiency and biological activity retention. Following initial purification, researchers should implement secondary purification steps such as size exclusion chromatography to separate monomeric from oligomeric forms, as the monomeric form represents the most biologically potent species in follicular fluid .
Quality control should include SDS-PAGE combined with western blotting for purity assessment and activity assays measuring proliferation effects on target cells like granulosa cells or Nb2 lymphoma cells. Researchers must verify that the His-tag does not interfere with receptor binding or downstream signaling pathways when designing experiments.
Experimental design for assessing prolactin's effects on sperm function requires careful consideration of multiple parameters. Based on current research, prolactin appears to act as a pro-survival factor by reducing reactive oxygen species in low-motile sperm subpopulations . When designing such experiments, researchers should:
Include appropriate concentration ranges (0.05-5.0 μg/mL based on existing studies)
Establish clear endpoints including:
Reactive oxygen species measurements
Sperm motility parameters (using computer-assisted sperm analysis)
Viability assessments (using fluorescent probes)
Acrosome reaction status
Zona pellucida binding capacity
Consider the timing of prolactin exposure, as effects may vary depending on sperm maturation stage
Include positive controls (known antioxidants) and negative controls
Evaluate potential synergistic effects with other follicular fluid components such as progesterone and myo-inositol
This methodological framework enables comprehensive assessment of prolactin's effects on sperm function while controlling for confounding variables.
Understanding prolactin dynamics during in vitro fertilization requires attention to several critical factors that influence hormone levels and biological responses. Research indicates that prolactin levels fluctuate significantly during stimulated cycles, showing distinct patterns from natural cycles . Key considerations include:
Timing of measurements: Prolactin exhibits a transient increase in the late follicular phase, with peaks observed:
Treatment protocol effects: Different IVF regimens significantly affect prolactin levels:
Relationship with other hormones: While some studies show positive correlations between estradiol and prolactin levels, others find no relationship
These considerations are essential for experimental design and interpretation of results when studying prolactin's role in assisted reproductive technologies.
Assay Type | Application | Sensitivity | Advantages | Limitations |
---|---|---|---|---|
Cell Counting Kit-8 (CCK-8) | Proliferation assessment | Detects changes in cell numbers as low as 10% | Non-radioactive, simple protocol, minimal steps | May be affected by metabolic changes unrelated to proliferation |
Flow Cytometry with Annexin V/PI | Apoptosis quantification | Detects early and late apoptosis with >95% accuracy | Distinguishes between apoptotic and necrotic cells | Requires specialized equipment, complex data interpretation |
ELISA | Hormone secretion (E2, P4) | Typically 10-50 pg/mL for E2; 0.1-0.5 ng/mL for P4 | High-throughput, quantitative, commercial kits available | Cross-reactivity with similar steroids possible |
RT-qPCR | Gene expression analysis | Can detect changes as low as 1.5-fold | Highly sensitive, quantitative, allows multiple gene analysis | RNA quality critical, requires normalization to reference genes |
Western Blot | Protein expression analysis | Semi-quantitative | Determines protein size and relative abundance | Labor-intensive, limited throughput |
GTPase Activity Assay | Tubulin function assessment | Can detect changes of approximately 20% in activity | Reflects functional impact on cytoskeleton dynamics | Technically challenging, influenced by multiple factors |
Optimal experimental design combines multiple complementary assays to provide comprehensive assessment of prolactin's biological activities across different cellular parameters .
Reconciling contradictory findings regarding prolactin's effects on fertility requires systematic evaluation of experimental variables. Current literature demonstrates apparent contradictions, with some studies reporting beneficial effects of higher prolactin levels on oocyte competence and pregnancy rates, while others suggest negative associations . These discrepancies likely reflect prolactin's complex biphasic effects and context-dependent actions.
When interpreting contradictory results, researchers should:
Carefully compare prolactin concentration ranges, as effects are highly dose-dependent
Consider the specific cell types or tissues examined, as prolactin receptors show differential distribution
Account for species differences, as findings from bovine or rodent models may not directly translate to ovine or human systems
Evaluate experimental timing, as prolactin's effects vary throughout the reproductive cycle
Assess interactions with other hormones, particularly gonadotropins and estradiol
This systematic approach helps identify whether contradictions represent true biological complexity or methodological differences.
Transient hyperprolactinemia during IVF stimulation appears to have complex physiological significance that remains incompletely understood. Research indicates that approximately 20% of patients undergoing IVF experience transient hyperprolactinemia, yet conception rates and pregnancy outcomes remain similar between patients with normal and elevated prolactin levels . This suggests that transient hyperprolactinemia may represent a physiological response rather than a pathological condition during ovarian stimulation.
The timing of prolactin elevation provides clues to its potential functions, with peaks occurring:
After HCG administration (potentially supporting final oocyte maturation)
Following ovum pickup (possibly promoting corpus luteum formation)
During the luteal phase (potentially enhancing progesterone production and endometrial receptivity)
Interestingly, patients with very low prolactin levels (<10 μg/L) demonstrate significantly lower fertilization and cleavage rates compared to those with normal or elevated prolactin , suggesting a minimum threshold of prolactin may be necessary for optimal reproductive outcomes.
Gene editing technologies, particularly CRISPR-Cas9, offer unprecedented opportunities to elucidate prolactin receptor signaling mechanisms in ovine reproductive tissues. By generating targeted modifications in prolactin receptor genes or downstream signaling components, researchers could:
Create receptor variants with altered binding domains to identify critical residues for ligand recognition
Develop cell lines with fluorescently tagged receptors to visualize trafficking and internalization dynamics
Generate tissue-specific receptor knockouts to dissect cell-type specific effects
Introduce mutations in specific signaling pathway components to determine their contributions to prolactin's diverse effects
These approaches would help resolve current questions regarding the dual effects of prolactin on steroidogenesis, its biphasic dose-dependent actions on oocyte maturation, and the molecular mechanisms underlying its effects on granulosa cell proliferation and apoptosis . Additionally, gene editing could help identify the specific signaling pathways responsible for prolactin's protective effects on low-motile sperm, potentially leading to novel therapeutic strategies for male subfertility.
Recombinant His-tagged ovine prolactin offers several promising applications in reproductive biotechnology based on current understanding of its biological activities. Potential applications include:
Culture medium supplementation: Evidence suggests that optimal prolactin concentrations (approximately 50 ng/mL) may protect cumulus-enclosed oocytes from aging-related chromosomal abnormalities , potentially improving IVF outcomes.
Sperm preparation: Prolactin's demonstrated ability to reduce reactive oxygen species in low-motile sperm suggests applications in treating subfertile semen samples . His-tagged versions would allow precise concentration control and easy removal after treatment.
Corpus luteum support: Prolactin's positive effects on corpus luteum formation and survival suggest potential applications in luteal phase support protocols.
Diagnostic applications: As differential prolactin responses to stimulation protocols have been observed , His-tagged prolactin could serve as a standard in diagnostic assays measuring prolactin receptor function or sensitivity.
Research tools: The well-defined binding and purification properties of His-tagged proteins make them valuable for identifying novel prolactin-interacting proteins in reproductive tissues through pull-down assays and proteomic analyses.
These applications highlight the potential translational value of continued research into ovine prolactin's reproductive functions.
Recombinant Ovine Prolactin is produced using Escherichia coli (E. coli) as the expression system . The recombinant protein is a single, non-glycosylated polypeptide chain that is fused to a 6x His Tag at the C-terminus . This His Tag facilitates the purification process through affinity chromatography, allowing for a high degree of purity .
The recombinant ovine prolactin is formulated as a sterile, filtered, colorless solution. It is typically stored in a buffer solution of 1X PBS (phosphate-buffered saline) with a pH of 7.2 and 50% glycerol . The protein is more than 90% pure as determined by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) .
For short-term storage (2-4 weeks), the recombinant protein can be kept at 4°C. For longer periods, it should be stored frozen at -20°C. To ensure stability during long-term storage, it is recommended to add a carrier protein such as 0.1% HSA (human serum albumin) or BSA (bovine serum albumin) . It is important to avoid multiple freeze-thaw cycles to maintain the protein’s integrity .